|国家预印本平台
首页|光动力-光热联合治疗的光敏剂分子设计合成与性能研究

光动力-光热联合治疗的光敏剂分子设计合成与性能研究

Molecular design, synthesis and properties of photosensitizers for photodynamic-photothermal combined therapy

中文摘要英文摘要

(光动力-光热联合治疗的新型光敏剂分子在研究中取得了重大进展,但在癌症的治疗方面仍存在缺陷。如能将光动力疗法和光热疗法结合,不仅可以克服PDT的局限性,还可以在癌症治疗效果上寻求重大突破。然而传统的联合治疗过程需要较长的光照时间导致患者不易术后恢复。出于简化治疗的目的,科学家门希望设计出具有PDT/PTT效果的光敏剂本文通过设计新型花菁染料分子-IR805,与ICG相比,在近红外长照射下,有着较好的热稳定性和光热转换能力。

photosensitizer molecules for photodynamic-photothermal combined therapy have made significant progress in research, but there are still deficiencies in the treatment of cancer. If photodynamic therapy and photothermal therapy can be combined, it can not only overcome the limitations of PDT, but also seek a major breakthrough in the effect of cancer treatment. However, the traditional combined treatment process requires a long light time, which makes it difficult for patients to recover after surgery. For the purpose of simplifying treatment, scientists hope to design a photosensitizer with PDT/PTT effect. In this paper, by designing a new cyanine dye molecule-IR805, compared with ICG, it has better thermal stability under near-infrared long irradiation. and light-to-heat conversion capability.

周千惠、袁林、袁婕

肿瘤学药学分子生物学

吲哚菁绿联合治疗光动力光热治疗

indocyanine greencombination therapyphotodynamicphotothermal therapy

周千惠,袁林,袁婕.光动力-光热联合治疗的光敏剂分子设计合成与性能研究[EB/OL].(2022-05-27)[2025-08-21].http://www.paper.edu.cn/releasepaper/content/202205-198.点此复制

评论